全文获取类型
收费全文 | 7489篇 |
免费 | 793篇 |
国内免费 | 421篇 |
学科分类
医药卫生 | 8703篇 |
出版年
2024年 | 40篇 |
2023年 | 158篇 |
2022年 | 366篇 |
2021年 | 475篇 |
2020年 | 361篇 |
2019年 | 316篇 |
2018年 | 312篇 |
2017年 | 267篇 |
2016年 | 215篇 |
2015年 | 379篇 |
2014年 | 422篇 |
2013年 | 382篇 |
2012年 | 589篇 |
2011年 | 594篇 |
2010年 | 329篇 |
2009年 | 242篇 |
2008年 | 327篇 |
2007年 | 339篇 |
2006年 | 349篇 |
2005年 | 391篇 |
2004年 | 217篇 |
2003年 | 203篇 |
2002年 | 168篇 |
2001年 | 128篇 |
2000年 | 149篇 |
1999年 | 166篇 |
1998年 | 84篇 |
1997年 | 73篇 |
1996年 | 69篇 |
1995年 | 62篇 |
1994年 | 71篇 |
1993年 | 29篇 |
1992年 | 59篇 |
1991年 | 56篇 |
1990年 | 38篇 |
1989年 | 45篇 |
1988年 | 31篇 |
1987年 | 34篇 |
1986年 | 18篇 |
1985年 | 19篇 |
1984年 | 18篇 |
1983年 | 5篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1979年 | 10篇 |
1978年 | 16篇 |
1973年 | 10篇 |
1972年 | 6篇 |
1967年 | 7篇 |
1966年 | 5篇 |
排序方式: 共有8703条查询结果,搜索用时 15 毫秒
1.
AbstractBackground: This study aims to compare the effectiveness of inhaled prostacyclin or its analoguesversus nitric oxide (NO) in treating pulmonary hypertension (PH) after cardiac or pulmonary surgery remains unclear.Methods: PubMed, Cochrane, and Embase databases were searched for literature published prior to December 2019 using the following keywords: inhaled, nitric oxide, prostacyclin, iloprost, treprostinil, epoprostenol, Tyvaso, flolan, and pulmonary hypertension. Randomized controlled trials and multiple-armed prospective studies that evaluated inhaled NO versus prostacyclin (or analogues) in patients for perioperative and/or postoperative PH after either cardiac or pulmonary surgery were included. Retrospective studies, reviews, letters, comments, editorials, and case reports were excluded.Results: Seven studies with a total of 195 patients were included. No difference in the improvement of mean pulmonary arterial pressure (pooled difference in mean change= ?0.10, 95% CI: ?3.98 to 3.78, p?=?.959) or pulmonary vascular resistance (pooled standardized difference in mean change= ?0.27, 95% CI: ?0.60 to 0.05, p?=?.099) were found between the two treatments. Similarly, no difference was found in other outcomes between the two treatments or subgroup analysis.Conclusions: Inhaled prostacyclin (or analogues) was comparable to inhaled NO in treating PH after cardiac or pulmonary surgery.
- Key messages
This study compared the efficacy of inhaled prostacyclin or its analogues versus inhaled NO to treat PH after surgery. The two types of agent exhibited similar efficacy in managing MPAP, PVR, heart rate, and cardiac output was observed.
Inhaled prostacyclin may serve as an alternative treatment option for PH after cardiac or pulmonary surgery.
2.
3.
Cardiotoxin, isolated from the venom of Naja naja atra, was found to cause rat hind-paw edema in a dose-dependent manner. This edematous response was significantly suppressed by pretreatment with diphenhydramine, methysergide or compound 48/80, which reduced the tissue histamine content. Polymorphonuclear (PMN) leukocyte infiltration appeared within 1 h and had accumulated markedly in the rat paw 3-6 h after subplantar injection of cardiotoxin. Methotrexate pretreatment significantly reduced not only the peripheral leukocyte count but also cardiotoxin-induced paw edema. Captopril, a kininase inhibitor, potentiated the edematous response caused by a low dose of cardiotoxin. The initial phase, occurring within 3 h, of paw edema induced by cardiotoxin was suppressed by trasylol, [Thi5,8,D-Phe7]bradykinin, or by cellulose sulfate pretreatment which greatly reduced plasma kininogen levels. Both mast cells and PMN leukocytes possess kinin-forming activities, but with different properties. The kinin-forming activity of mast cells but not of PMN leukocytes was inhibited by trasylol. In isolated mast cells, cardiotoxin caused a dose-dependent release of histamine, beta-glucuronidase, lactate dehydrogenase and kinin-forming activity. These observations suggest that mast cells and PMN leukocytes are involved in cardiotoxin-induced paw edema, and that inflammatory mediators such as histamine, serotonin and kinins were supplied directly or indirectly by mast cells, at least in the initial phase. 相似文献
4.
风心病并发脑栓塞病人的瓣膜替换术 总被引:11,自引:0,他引:11
报告64例风心病并发脑栓塞病人的瓣膜替换术。术前心功能I级10例、II级38例、IV级16例。伴房颤者54例。脑栓塞史半年以上者44例,6个月以内20例,其中2个月以内者14例。34例有程度不同的脑栓塞后遗症。行二尖瓣替换术47例、双瓣膜替换术17例,同期行三尖瓣环环缩或成形术43例。术中证实有左房血栓25例(39%)。手术死亡率6.25%。术后并发颅内出血和栓塞各1例。结果表明风心病并发脑栓塞病人的手术效果良好。作者指出,脑栓塞2个月以上者应尽早手术,2个月以内者则应根据脑栓塞程度、恢复情况及有无左房血栓,选择手术时机。并介绍了围术期的处理经验。 相似文献
5.
6.
7.
目的通过对国人脑池显微解剖的研究,以指导显微神经外科手术和进一步理解影像学解剖的重要临床意义和应用价值。方法对15具经福尔马林固定的国人成年头颅标本的颅内各个脑池进行显微解剖研究,测量和描述各脑池的位置、大小、形态及结构。结果颅内重要的脑池有(1)嗅池:长度为(32.68±2.97)mm,宽度为(7.18±1.82)mm,深度为(7.20±1.27)mm;(2)视交叉池:侧壁长度为(14.88±3.07)mm,上表面前壁长(14.20±1.47)mm,后壁长(10.37±1.59)mm;(3)颈内动脉池:长度为(15.06±3.07)mm,宽度为(12.01±1.32)mm;(4)终板池:底边左侧长度为(8.99±1.15)mm,右侧长度为(21.00±1.09)mm,最大宽径为(16.42±2.58)mm;(5)脚间池:最大深度为(19.47±2.28)mm,池顶宽度为(11.35±2.85)mm;(6)脚池:为三角形,三边长度分别为(10.48±2.56)mm,(9.64±1.78)mm,(3.58±0.25)mm;(7)外侧裂池:上部长度为(18.63±2.02)mm,基底部长度为(38.08±3.22)mm,宽度为(5.65±0.92)mm,深度为(7.02±2.28)mm;(8)胼胝体池:平均最大宽径为(3.44±0.40)mm;(9)四叠体池:最大长径为(19.37±3.38)mm,最大宽径为(15.24±2.37)mm,最大前后径为(3.65±0.57)mm;(10)环池:为环形,最大宽度为(3.16±0.37)mm;(11)小脑延髓池:最大长度为(18.77±1.77)mm,最大宽度为(32.4 相似文献
8.
逆行交锁髓内钉治疗股骨髁上骨折及关节僵硬 总被引:2,自引:0,他引:2
目的:探讨应用逆行交锁强内钉治疗陈旧性股骨碟上骨折钢板断裂不愈合并膝关节僵硬的临床意义。方法:对5例患采用断裂钢板拆除,手术松解粘连,矫正畸形,股骨碟逆行交锁铝内钉固定,术后早期应用CPM机锻炼。结果:5例随访8—12个月,肢体无畸形,骨折愈合时间6—9个月,平均7.5个月,膝关节功能按Kolmert评定标准,优4例,良1例。结论:应用逆行交锁铝内钉治疗股骨碟上陈旧性骨折钢板断裂骨不愈合并膝关节僵硬,操作简便,固定牢靠,可早期功能锻炼,效果良好。 相似文献
9.
10.